Preclinical Contract Research
Advance Your Discovery with Trusted Preclinical Contract Research
When it comes to bringing new therapies and technologies to life, choosing the right preclinical contract research partner makes all the difference. At Lovelace Biomedical, we offer comprehensive preclinical contract research services designed to accelerate your path from concept to clinical trials. With decades of experience and a legacy of scientific excellence, our team is committed to helping pharmaceutical, biotech, and medical device companies achieve regulatory success through reliable, high-quality preclinical contract research.
End-to-End Preclinical Contract Research Solutions
Lovelace Biomedical specializes in full-service preclinical contract research, providing tailored solutions that support the complex needs of early-stage drug development. Our expert scientists and technicians deliver robust study designs, precise execution, and comprehensive reporting across a range of therapeutic areas. Whether you need toxicology, pharmacology, or bioanalytical services, our preclinical contract research programs are built to meet the highest standards in GLP and non-GLP studies.
Our preclinical contract research services include:
- General and specialty toxicology studies
- Pharmacokinetics (PK) and pharmacodynamics (PD)
- Inhalation toxicology and exposure systems
- IND-enabling studies
- Safety pharmacology
- Bioanalytical testing and method development
Every preclinical contract research project at Lovelace Biomedical is guided by scientific rigor, regulatory compliance, and a deep understanding of your product development goals.
Special Expertise in Inhalation Preclinical Contract Research
We understand that selecting a preclinical contract research partner is more than just outsourcing a study—it’s about building a relationship grounded in trust, expertise, and transparency. At Lovelace Biomedical, our team collaborates closely with clients to ensure that each preclinical contract research study is tailored to deliver the data needed for regulatory submission and decision-making. Our state-of-the-art facilities are designed to support a wide array of preclinical contract research services, including highly specialized areas such as inhalation drug delivery, neuropharmacology, and advanced analytics. From first-in-animal studies to comprehensive IND packages, our preclinical contract research capabilities provide the foundation for scientific advancement and clinical success.
Regulatory Excellence in Life Science Research
Lovelace Biomedical is uniquely positioned as a global leader in inhalation preclinical contract research. With decades of experience in aerosol generation, respiratory delivery systems, and lung pathology, we help clients develop therapies targeted to respiratory conditions and beyond. Our inhalation expertise enhances our broader preclinical contract research offerings, enabling precision in dosing, delivery, and outcome measurement.
Partner with a Preclinical Contract Research Leader
Our goal is to simplify the development journey while maintaining scientific integrity. That’s why Lovelace Biomedical remains a trusted name in preclinical contract research across the industry. We are driven by innovation, supported by a team of multidisciplinary experts, and committed to helping our partners navigate complex development milestones. When you choose Lovelace Biomedical for your preclinical contract research needs, you gain more than a service provider—you gain a strategic partner invested in your success. From small molecules to biologics, medical devices to gene therapies, we bring insight and precision to every preclinical contract research program we support.
Get Started Today with Preclinical Contract Research at Lovelace Biomedical
Ready to elevate your development pipeline? Contact Lovelace Biomedical to learn more about our world-class preclinical contract research capabilities. Let us help you turn scientific potential into regulatory success. Reach out to our Business Development office to learn more about our preclinical contract research solutions.